Correction: Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial.
Maarten A Huismans
,
Eelke H Gort
,
Lisa T van der Heijden
,
Sermin M Guven Mese
,
Helena M Klein Wolterink
,
Manon N G J A Braat
,
Sjoerd G Elias
,
Filip Y F L de Vos
,
Lot A Devriese
,
Henk M W Verheul
,
Frans L Opdam
,
Miriam Koopman
,
Hilde H Nienhuis
,
Heleen A Crommelin
,
Hugo J G Snippert
,
Alwin D R Huitema
,
Jeanine M L Roodhart
More about this publication
British journal of cancer
Publication date
25-09-2026
Full text links
Publisher website (DOI)
10.1038/s41416-026-03616-6
Europe PubMed Central
42791320
Pubmed
42791320